Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved. The company’s primary pharmaceutical candidate, Apta-1, is being developed with the aim of preventing the high mortality rate caused by organ and tissue damage in patients diagnosed with a septic condition, among others. The company holds patent protection in strategic target markets and actively seeks business development opportunities with potential collaborators.
View Top Employees from AptahemWebsite | https://aptahem.com/ |
Revenue | $9 million |
Employees | 8 (2 on RocketReach) |
Founded | 2014 |
Address | 58 Norra Vallgatan, Malmoe, Skane 211 22, SE |
Phone | +46 76 633 36 99 |
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Aptahem employee's phone or email?
The Aptahem annual revenue was $9 million in 2024.
2 people are employed at Aptahem.
Aptahem is based in Malmoe, Skane.
The NAICS codes for Aptahem are [541, 541713, 54, 54171, 5417].
The SIC codes for Aptahem are [873, 87].